Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
---|---|---|---|---|---|
PMID:10188194 | IVR | 750 mg/kg/day | 750 mg/kg/day | Affects embryonic development | Developmental endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in epididymal morphology | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in testicular morphology | Reproductive endocrine-mediated perturbations | |
PMID:10762434 | IVR | 1 % | 1 % | Increased liver weights | Hepatic endocrine-mediated perturbations |
IVR | 2 % | 2 % | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 2 % | 2 % | Changes in liver morphology | Hepatic endocrine-mediated perturbations | |
IVR | 2 % | 2 % | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
PMID:11099646 | IVR | 750 mg/kg/day | 750 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Altered germ cells morphology | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Alterations in number of leydig cells | Reproductive endocrine-mediated perturbations | |
PMID:11099647 | IVR | 750 mg/kg/day | 750 mg/kg/day | Affects developmental process | Developmental endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects embryonic development | Developmental endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Undescended testes (or cryptorchidism) | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in mammary gland morphology | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in testicular morphology | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Nipple retention | Reproductive endocrine-mediated perturbations | |
PMID:12083789 | IVR | 0.004 M | 0.004 M | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 0.004 M | 0.004 M | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 0.0008 M | 0.0008 M | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.0008 M | 0.0008 M | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
PMID:14692339 | IVR | 0.00001 M | 0.00001 M | Alterations in splenocytes population | Immunological endocrine-mediated perturbations |
IVR | 0.00001 M | 0.00001 M | Changes in thymus gland morphology | Immunological endocrine-mediated perturbations | |
PMID:15013064 | IVR | 750 mg/kg/day | 750 mg/kg/day | Increased LH levels | Reproductive endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in number of nipples | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased inhibin-B levels | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
PMID:15229365 | IVR | 2.6 mmol/kg | 2.6 mmol/kg | Affects tryptophan metabolism | Metabolic endocrine-mediated perturbations |
PMID:15379967 | IVR | 2 % | 2 % | Decreased testis weights | Reproductive endocrine-mediated perturbations |
IVR | 2 % | 2 % | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
PMID:15518916 | IVR | 0.087 M | 0.087 M | Affects neuronal signaling | Neurological endocrine-mediated perturbations |
IVR | 0.087 M | 0.087 M | Affects ovulation | Reproductive endocrine-mediated perturbations | |
IVR | 0.087 M | 0.087 M | Affects dopaminergic pathways | Neurological endocrine-mediated perturbations | |
IVR | 0.087 M | 0.087 M | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 0.087 M | 0.087 M | Affects insulin signaling | Metabolic endocrine-mediated perturbations | |
PMID:15620428 | IVR | 0.087 M | 0.087 M | Affects social behavior | Neurological endocrine-mediated perturbations |
IVR | 0.087 M | 0.087 M | Affects neuronal signaling | Neurological endocrine-mediated perturbations | |
PMID:15883486 | IVTH | 0.000000001 - 0.001 M | 0.000001 - 0.0001 M | Cancer phenotype | Endocrine-mediated cancer |
PMID:16400681 | IVR | 1400 mg/kg | 1400 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 1400 mg/kg | 1400 mg/kg | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 1400 mg/kg | 1400 mg/kg | Decreased LH levels | Reproductive endocrine-mediated perturbations | |
IVR | 1400 mg/kg | 1400 mg/kg | Decreased FSH levels | Reproductive endocrine-mediated perturbations | |
IVR | 1400 mg/kg | 1400 mg/kg | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
PMID:16949715 | IVR | 135 mg | 135 mg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 0.405 mg | 0.405 mg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.135 mg | 0.135 mg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 45 mg | 45 mg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1.22 mg | 1.22 mg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 405 mg | 405 mg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 15 mg | 15 mg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.015 mg | 0.015 mg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 5 mg | - | No significant effects observed | - | |
IVR | 0.045 mg | - | No significant effects observed | - | |
PMID:17229994 | IVR | 250 mg/kg | 250 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations |
IVR | 10 mg/kg | 10 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
PMID:17286146 | IVTH | 0 NA | - | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations |
PMID:17558187 | IVR | 250 mg/kg | 250 mg/kg | Affects spermatogenesis | Reproductive endocrine-mediated perturbations |
IVR | 10 mg/kg | 10 mg/kg | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
PMID:17654256 | IVR | 500 mg/kg | 500 mg/kg | Increased liver weights | Hepatic endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Increased prostate weights | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Decreased weights of seminal vesicles | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Decreased weights of seminal vesicles | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Increased weights of bulbocavernosus muscles/LABC | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Increased prostate weights | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg | 20 mg/kg | Increased prostate weights | Reproductive endocrine-mediated perturbations | |
PMID:17679765 | IVR | 250 mg/kg | 250 mg/kg | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations |
IVR | 10 mg/kg | 10 mg/kg | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
PMID:18322279 | IVR | 700 mg/kg/day | 700 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations |
IVR | 700 mg/kg/day | 700 mg/kg/day | Alterations in number of leydig cells | Reproductive endocrine-mediated perturbations | |
IVR | 1250 mg/kg/day | 1250 mg/kg/day | Abnormal development of gonads in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1250 mg/kg/day | 1250 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 1250 mg/kg/day | 1250 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1250 mg/kg/day | 1250 mg/kg/day | Alterations in number of leydig cells | Reproductive endocrine-mediated perturbations | |
IVR | 1250 mg/kg/day | 1250 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Alterations in number of leydig cells | Reproductive endocrine-mediated perturbations | |
IVR | 469 mg/kg/day | 469 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 469 mg/kg/day | 469 mg/kg/day | Alterations in number of leydig cells | Reproductive endocrine-mediated perturbations | |
IVR | 469 mg/kg/day | 469 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 469 mg/kg/day | 469 mg/kg/day | Abnormal development of gonads in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 234 mg/kg/day | 234 mg/kg/day | Alterations in number of leydig cells | Reproductive endocrine-mediated perturbations | |
IVR | 234 mg/kg/day | 234 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 938 mg/kg/day | 938 mg/kg/day | Alterations in number of leydig cells | Reproductive endocrine-mediated perturbations | |
IVR | 938 mg/kg/day | 938 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
PMID:19367084 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Reduced sperm quality | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased testosterone levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased LH levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Undescended testes (or cryptorchidism) | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects testis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Changes in number of nipples | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Reduced sperm quality | Reproductive endocrine-mediated perturbations | |
PMID:19428328 | IVR | 200 mg/kg/day | 200 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects fatty acid metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects cholesterol biosynthesis | Metabolic endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
IVTH | 0.0001 M | 0.0001 M | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects cholesterol biosynthesis | Metabolic endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects fatty acid metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
PMID:19577633 | IVR | 500 mg/kg/day | 500 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Undescended testes (or cryptorchidism) | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects survival of live fetus | Reproductive endocrine-mediated perturbations | |
PMID:19781091 | IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased weights of seminal vesicles | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased prostate weights | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased weights of accessory sex organs | Reproductive endocrine-mediated perturbations | |
PMID:20568448 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects testicular morphology | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Changes in epididymal morphology | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects testicular morphology | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Changes in epididymal morphology | Reproductive endocrine-mediated perturbations | |
PMID:21636974 | IVR | 750 mg/kg/day | 750 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
PMID:21673306 | IVR | 1.25 mg/kg/day | 1.25 mg/kg/day | Affects pancreas development | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations |
IVR | 1.25 mg/kg/day | 1.25 mg/kg/day | Beta cell dysfunction | Metabolic endocrine-mediated perturbations | |
IVR | 1.25 mg/kg/day | 1.25 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 1.25 mg/kg/day | 1.25 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 1.25 mg/kg/day | 1.25 mg/kg/day | Reduced insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 6.25 mg/kg/day | 6.25 mg/kg/day | Affects pancreas development | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 6.25 mg/kg/day | 6.25 mg/kg/day | Beta cell dysfunction | Metabolic endocrine-mediated perturbations | |
IVR | 6.25 mg/kg/day | 6.25 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 6.25 mg/kg/day | 6.25 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 6.25 mg/kg/day | 6.25 mg/kg/day | Reduced insulin levels | Metabolic endocrine-mediated perturbations | |
PMID:22279657 | IVR | 150 mg/kg/day | 150 mg/kg/day | Decreased FSH levels | Reproductive endocrine-mediated perturbations |
IVR | 150 mg/kg/day | 150 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 150 mg/kg/day | 150 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 150 mg/kg/day | 150 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 150 mg/kg/day | 150 mg/kg/day | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 150 mg/kg/day | 150 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Alterations in vaginal opening | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased FSH levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
PMID:22986106 | IVR | 500 mg/kg | 500 mg/kg | Decreased progesterone levels | Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg | 500 mg/kg | Induce apoptosis of granulosa cells | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg | 2000 mg/kg | Induce apoptosis of granulosa cells | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg | 2000 mg/kg | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg | 2000 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg | 2000 mg/kg | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 125 mg/kg | - | No significant effects observed | - | |
IVR | 500 mg/kg | 500 mg/kg | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
PMID:23046697 | IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects implantation | Reproductive endocrine-mediated perturbations |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Compromised endometrial receptivity | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects intracellular signaling pathway | Metabolic endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects the normal functioning of reproductive system | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | - | No significant effects observed | - | |
IVR | 250 mg/kg/day | - | No significant effects observed | - | |
PMID:23277027 | IVR | 0.5 mg/kg | 0.5 mg/kg | Lead to obesity | Metabolic endocrine-mediated perturbations |
PMID:23536373 | IVR | 500 mg/kg/day | 500 mg/kg/day | Affects spermatogenesis | Reproductive endocrine-mediated perturbations |
PMID:23625783 | IVR | 0.02 mg/kg | 0.02 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations |
IVR | 0.02 mg/kg | 0.02 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg | 0.02 mg/kg | Affects ovarian function | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Affects ovarian function | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
PMID:23892333 | IVR | 0.01 % | 0.01 % | Changes in T-cell populations | Immunological endocrine-mediated perturbations |
IVR | 0.01 % | 0.01 % | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 0.1 % | 0.1 % | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.1 % | 0.1 % | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 0.1 % | 0.1 % | Changes in T-cell populations | Immunological endocrine-mediated perturbations | |
PMID:24390239 | IVR | 0.04 mg/kg/day | 0.04 mg/kg/day | Affects embryonic development | Developmental endocrine-mediated perturbations |
PMID:24564399 | IVR | 1 - 300 mg/kg/day | 100 - 300 mg/kg/day | Decreased aldosterone levels | Metabolic endocrine-mediated perturbations |
PMID:24641848 | IVR | 500 mg/kg | 500 mg/kg | Decreased testosterone levels | Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg | 500 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 80 mg/kg | 80 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 80 mg/kg | 80 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 80 mg/kg | 80 mg/kg | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
PMID:24675100 | IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased ovarian weights | Reproductive endocrine-mediated perturbations |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Alters hypothalamic-pituitary-ovarian axis | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 3000 mg/kg/day | 3000 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 3000 mg/kg/day | 3000 mg/kg/day | Alters hypothalamic-pituitary-ovarian axis | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 3000 mg/kg/day | 3000 mg/kg/day | Decreased ovarian weights | Reproductive endocrine-mediated perturbations | |
PMID:24799162 | IVR | 1 mg/kg/day | 1 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects cytokine signaling | Immunological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
PMID:24804967 | IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Increased spleen weights | Immunological endocrine-mediated perturbations |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
PMID:24811840 | IVR | 80 mg/kg/day | 80 mg/kg/day | Affects the normal functioning of reproductive system | Reproductive endocrine-mediated perturbations |
PMID:24950685 | IVTH | 0.00005 M | 0.00005 M | Decreased estradiol levels | Reproductive endocrine-mediated perturbations |
IVTH | 0.00005 M | 0.00005 M | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00005 M | 0.00005 M | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVTH | 0.000005 M | 0.000005 M | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVTH | 0.000005 M | 0.000005 M | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.000005 M | 0.000005 M | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVTH | 0.0000005 M | - | No significant effects observed | - | |
PMID:25016925 | IVTH | 0.000000001 - 0.000001 M | 0.000000001 - 0.000001 M | Cancer phenotype | Endocrine-mediated cancer |
IVTH | 0.000000001 - 0.000001 M | 0.000000001 - 0.000001 M | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
PMID:25152515 | IVR | 500 mg/kg | 500 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg | 500 mg/kg | Affects androgen production | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg | 300 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg | 300 mg/kg | Affects androgen production | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg | 300 mg/kg | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg | 300 mg/kg | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Affects androgen production | Reproductive endocrine-mediated perturbations | |
PMID:25232145 | IVR | 1 mg/kg/day | 1 mg/kg/day | Affects glucose metabolism | Metabolic endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Elevated insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Elevated insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects glucose metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Elevated insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects glucose metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
PMID:25242624 | IVR | 500 mg/kg | 500 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Decreased weights of accessory sex organs | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Decreased weights of accessory sex organs | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Decreased weights of accessory sex organs | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg | 1000 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg | 20 mg/kg | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg | 20 mg/kg | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg | 20 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg | 20 mg/kg | Decreased testis weights | Reproductive | |
IVR | 20 mg/kg | 20 mg/kg | Decreased weights of accessory sex organs | ||
IVR | 20 mg/kg | 20 mg/kg | Decreased weights of epididymis | ||
IVR | 100 mg/kg | 100 mg/kg | Reduced sperm counts | ||
IVR | 20 mg/kg | 20 mg/kg | Affects spermatogenesis | ||
IVR | 100 mg/kg | 100 mg/kg | Decreased weights of epididymis | ||
PMID:25280772 | IVR | 1 mg/kg/day | 1 mg/kg/day | Beta cell dysfunction | Metabolic endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Elevated insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Elevated insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Beta cell dysfunction | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Elevated insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Elevated glucose levels | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Beta cell dysfunction | Metabolic endocrine-mediated perturbations | |
PMID:25330100 | IVR | 1 mg/kg/day | 1 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
PMID:25352649 | IVR | 1 mg/kg/day | 1 mg/kg/day | Induce neuronal apoptosis | Neurological endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Oxidative stress in sertoli cells | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Induce neuronal apoptosis | Neurological endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Oxidative stress in sertoli cells | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Induce neuronal apoptosis | Neurological endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Oxidative stress in sertoli cells | Reproductive endocrine-mediated perturbations | |
PMID:25530038 | IVR | 1 mg/kg/day | 1 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Increased FSH levels | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Decreased estrogen levels | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Increased FSH levels | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased estrogen levels | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Increased FSH levels | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects litter size | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects fertility | Reproductive endocrine-mediated perturbations | |
PMID:25766500 | IVTH | 0.000001 mmol | 0.000001 mmol | Affects the biochemical composition of liver | Hepatic endocrine-mediated perturbations |
IVTH | 0.000001 mmol | 0.000001 mmol | Affects expression of estrogen receptor-alpha (ER-alpha) | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00000001 mmol | 0.00000001 mmol | Affects the biochemical composition of liver | Hepatic endocrine-mediated perturbations | |
IVTH | 0.00000001 mmol | 0.00000001 mmol | Affects expression of estrogen receptor-alpha (ER-alpha) | Reproductive endocrine-mediated perturbations | |
IVTH | 0.0000001 mmol | 0.0000001 mmol | Affects expression of estrogen receptor-alpha (ER-alpha) | Reproductive endocrine-mediated perturbations | |
IVTH | 0.0000001 mmol | 0.0000001 mmol | Affects the biochemical composition of liver | Hepatic endocrine-mediated perturbations | |
PMID:25853433 | IVR | 750 mg/kg/day | 750 mg/kg/day | Alters mammary gland development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
PMID:25870019 | IVR | 200 mg/kg/day | 200 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects spatial memory | Neurological endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects locomotor activity | Neurological endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects locomotor activity | Neurological endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects spatial memory | Neurological endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects locomotor activity | Neurological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects spatial memory | Neurological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:25881014 | IVR | 100 mg/kg | 100 mg/kg | Affects glucose metabolism | Metabolic endocrine-mediated perturbations |
PMID:26035430 | IVR | 750 mg/kg | 750 mg/kg | Undescended testes (or cryptorchidism) | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
PMID:26147211 | IVR | 750 mg/kg | 750 mg/kg | Undescended testes (or cryptorchidism) | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
PMID:26170149 | IVR | 0.16 mg/kg/day | 0.16 mg/kg/day | Occurrence of mammary gland tumor | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations |
IVR | 0.08 mg/kg/day | 0.08 mg/kg/day | Occurrence of mammary gland tumor | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Occurrence of mammary gland tumor | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg/day | 0.04 mg/kg/day | Occurrence of mammary gland tumor | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
PMID:26244509 | IVR | 300 mg/kg/day | 300 mg/kg/day | Affects spermatogenesis | Reproductive endocrine-mediated perturbations |
PMID:26316063 | IVR | 10 mg/kg | 10 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations |
IVR | 10 mg/kg | 10 mg/kg | Affects sertoli cells function | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg | 10 mg/kg | Affects leydig cells function | Reproductive endocrine-mediated perturbations | |
PMID:26372177 | IVR | 0.05 mg/kg | 0.05 mg/kg | Affects testicular development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 0.05 mg/kg | 0.05 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg | 0.05 mg/kg | Affects testicular function | Reproductive endocrine-mediated perturbations | |
IVR | 0.005 mg/kg | 0.005 mg/kg | Affects testicular development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.005 mg/kg | 0.005 mg/kg | Affects testicular function | Reproductive endocrine-mediated perturbations | |
PMID:26524146 | IVR | 1 mg/kg/day | 1 mg/kg/day | Affects dopaminergic pathways | Neurological endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Decreased dopamine levels | Neurological endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects dopaminergic pathways | Neurological endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects dopaminergic pathways | Neurological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects expression of estrogen receptor-beta (ER-beta) | Reproductive endocrine-mediated perturbations | |
PMID:26558472 | IVR | 100 mg/kg | 100 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations |
IVR | 300 mg/kg | 300 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg | - | No significant effects observed | - | |
PMID:26678702 | IVR | 200 mg/kg/day | 200 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Induce apoptosis of ovarian follicles | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Decreased inhibin-B levels | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | - | No significant effects observed | - | |
IVR | 0.2 mg/kg/day | - | No significant effects observed | - | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Induce apoptosis of ovarian follicles | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased estradiol/progesterone ratio | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased inhibin-B levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Induce apoptosis of ovarian follicles | Reproductive endocrine-mediated perturbations | |
PMID:26844866 | IVR | 1 mg/kg/day | 1 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
PMID:26845775 | IVR | 0.02 mg/kg | 0.02 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations |
IVR | 0.02 mg/kg | 0.02 mg/kg | Oxidative stress in ovaries | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Oxidative stress in ovaries | Reproductive endocrine-mediated perturbations | |
PMID:27040317 | IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
PMID:27103539 | IVR | 500 mg/kg/day | 500 mg/kg/day | Delayed puberty | Reproductive endocrine-mediated perturbations |
PMID:27135907 | IVTH | 0.000000001 - 0.0000001 M | 0.000000001 - 0.0000001 M | Affects steroidogenesis | Reproductive endocrine-mediated perturbations |
IVTH | 0.000000001 - 0.0000001 M | 0.000000001 - 0.0000001 M | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
PMID:27405655 | IVR | 0.02 mg/kg | 0.02 mg/kg | Alterations in immune responses | Immunological endocrine-mediated perturbations |
IVR | 0.02 mg/kg | 0.02 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg | 0.02 mg/kg | Decreased androstenedione levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg | 0.02 mg/kg | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg | 0.02 mg/kg | Decreased LH levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg | 0.02 mg/kg | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Decreased androstenedione levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Decreased LH levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
PMID:27472966 | IVR | 1 mg/kg/day | 1 mg/kg/day | Abnormal neuronal distribution | Neurological endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Abnormal neuronal distribution | Neurological endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Abnormal neuronal distribution | Neurological endocrine-mediated perturbations | |
PMID:27639664 | IVR | 750 mg/kg/day | 750 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations |
PMID:27845755 | IVR | 500 mg/kg/day | 500 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 250 mg/kg/day | 250 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:27849367 | IVR | 1 mg/kg/day | 1 mg/kg/day | Affects thyroid hormone metabolism | Metabolic endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Decreased aldosterone levels | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects thyroid hormone metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased aldosterone levels | Metabolic endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased aldosterone levels | Metabolic endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects thyroid hormone metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Affects thyroid hormone metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Decreased aldosterone levels | Metabolic endocrine-mediated perturbations | |
IVR | 0.5 mg/kg/day | 0.5 mg/kg/day | Decreased aldosterone levels | Metabolic endocrine-mediated perturbations | |
IVR | 0.5 mg/kg/day | 0.5 mg/kg/day | Affects thyroid hormone metabolism | Metabolic endocrine-mediated perturbations | |
PMID:27956250 | IVR | 200 mg/kg | 200 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations |
IVR | 200 mg/kg | 200 mg/kg | Decreased placental weights | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Changes in placental morphology | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Changes in placental morphology | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Decreased placental weights | Reproductive endocrine-mediated perturbations | |
PMID:28025108 | IVR | 5 mg/kg | 5 mg/kg | Affects insulin signaling | Metabolic endocrine-mediated perturbations |
IVR | 5 mg/kg | 5 mg/kg | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Affects insulin signaling | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Impaired glucose tolerance | Metabolic endocrine-mediated perturbations | |
IVR | 0.05 mg/kg | - | No significant effects observed | - | |
PMID:28065941 | IVR | 500 mg/kg/day | 500 mg/kg/day | Oxidative stress in liver | Hepatic endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Changes in morphology of thyroid gland | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decrease in T3 levels | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decrease in Thyrotropin-releasing hormone (TRH) levels | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Changes in liver morphology | Hepatic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in liver morphology | Hepatic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Oxidative stress in liver | Hepatic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decrease in Thyrotropin-releasing hormone (TRH) levels | Metabolic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in morphology of thyroid gland | Metabolic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decrease in T3 levels | Metabolic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Oxidative stress in liver | Hepatic endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Changes in morphology of thyroid gland | Metabolic endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Changes in liver morphology | Hepatic endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Decrease in T3 levels | Metabolic endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Decrease in Thyrotropin-releasing hormone (TRH) levels | Metabolic endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
PMID:28082598 | IVR | 100 mg/kg/day | 100 mg/kg/day | Increased LH levels | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects fertility | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Increased LH levels | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects fertility | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Affects fertility | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Increased LH levels | Reproductive endocrine-mediated perturbations | |
IVR | 375 mg/kg/day | 375 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 375 mg/kg/day | 375 mg/kg/day | Affects fertility | Reproductive endocrine-mediated perturbations | |
IVR | 375 mg/kg/day | 375 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
IVR | 375 mg/kg/day | 375 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 375 mg/kg/day | 375 mg/kg/day | Increased estradiol levels | Reproductive | |
IVR | 375 mg/kg/day | 375 mg/kg/day | Increased LH levels | ||
PMID:28085963 | IVR | 300 mg/kg/day | 300 mg/kg/day | Induce apoptosis in testis | Reproductive endocrine-mediated perturbations |
IVR | 300 mg/kg/day | 300 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
PMID:28123099 | IVR | 5 mg/kg | 5 mg/kg | Affects sertoli cells function | Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg | 500 mg/kg | Affects skeletal development | Developmental endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Affects survival of live fetus | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg | 250 mg/kg | Affects skeletal development | Developmental endocrine-mediated perturbations | |
IVR | 250 mg/kg | 250 mg/kg | Affects sertoli cells function | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg | 250 mg/kg | Affects survival of live fetus | Reproductive endocrine-mediated perturbations | |
PMID:28199414 | IVR | 0.4 mg/kg | 0.4 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations |
IVR | 0.005 mg/kg | 0.005 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 0.04 mg/kg | 0.04 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
PMID:28286118 | IVR | 5 mg/kg/day | 5 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations |
IVR | 5 mg/kg/day | 5 mg/kg/day | Affects implantation | Reproductive endocrine-mediated perturbations | |
IVR | 5 mg/kg/day | 5 mg/kg/day | Affects ovulation | Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Affects implantation | Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Affects ovulation | Reproductive endocrine-mediated perturbations | |
PMID:28532275 | IVR | 500 mg/kg/day | 500 mg/kg/day | Induce apoptosis in testis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects testicular function in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased testis weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:28609104 | IVR | 522 mg/kg/day | 522 mg/kg/day | Affects lipid metabolism | Metabolic endocrine-mediated perturbations |
IVR | 522 mg/kg/day | 522 mg/kg/day | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 522 mg/kg/day | 522 mg/kg/day | Affects glucose metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 522 mg/kg/day | 522 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations | |
PMID:28634325 | IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased Alanine aminotransferase (ALT) levels | Hepatic endocrine-mediated perturbations |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects testicular morphology | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Decreased Alanine aminotransferase (ALT) levels | Hepatic endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Affects testicular morphology | Reproductive endocrine-mediated perturbations | |
PMID:28871463 | IVR | 10 mg/kg | 10 mg/kg | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations |
IVR | 10 mg/kg | 10 mg/kg | Affects development of reproductive system | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 2 mg/kg | 2 mg/kg | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 2 mg/kg | 2 mg/kg | Increased prostate weights | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:28915506 | IVR | 500 mg/kg/day | 500 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Lead to obesity | Metabolic endocrine-mediated perturbations | |
PMID:28934723 | IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 0.005 mg/kg/day | 0.005 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.0005 mg/kg/day | - | No significant effects observed | - | |
PMID:28972901 | IVR | 300 mg/kg/day | 300 mg/kg/day | Changes in white blood cell (WBC) populations | Immunological endocrine-mediated perturbations |
IVR | 300 mg/kg/day | 300 mg/kg/day | Pregnancy complications | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Pregnancy complications | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Changes in white blood cell (WBC) populations | Immunological endocrine-mediated perturbations | |
PMID:29144988 | IVR | 4 mg/kg | 4 mg/kg | Cancer phenotype | Endocrine-mediated cancer |
IVR | 4 mg/kg | 4 mg/kg | Induce tumor progression | Endocrine-mediated cancer | |
IVR | 4 mg/kg | 4 mg/kg | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
PMID:29158199 | IVR | 5 mg/kg/day | 5 mg/kg/day | Alterations in number of sertoli cells | Reproductive endocrine-mediated perturbations |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Alterations in number of sertoli cells | Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.0005 mg/kg/day | 0.0005 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 5 mg/kg/day | 5 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
PMID:29165555 | IVR | 500 mg/kg/day | 500 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Increased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Increased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Increased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Increased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Increased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
PMID:29225205 | IVR | 500 mg/kg/day | 500 mg/kg/day | Decrease in T3 levels | Metabolic endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Increase in Thyrotropin-releasing hormone (TRH) levels | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
IVR | 50 mg/kg/day | 50 mg/kg/day | Increase in Thyrotropin-releasing hormone (TRH) levels | Metabolic endocrine-mediated perturbations | |
IVR | 5 mg/kg/day | - | No significant effects observed | - | |
PMID:29228129 | IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Decreased liver weights | Hepatic endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Decreased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
PMID:29280353 | IVR | 0.05 mg/kg | 0.05 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations |
IVR | 0.005 mg/kg | 0.005 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations | |
IVR | 0.005 mg/kg | 0.005 mg/kg | Affects expression of androgen receptor (AR) | Reproductive endocrine-mediated perturbations | |
IVR | 0.005 mg/kg | 0.005 mg/kg | Affects the normal functioning of reproductive system | Reproductive endocrine-mediated perturbations | |
PMID:29385306 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations |
IVR | 400 mg/kg/day | 400 mg/kg/day | Induce apoptosis of granulosa cells | Reproductive endocrine-mediated perturbations | |
IVR | 400 mg/kg/day | 400 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1600 mg/kg/day | 1600 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1600 mg/kg/day | 1600 mg/kg/day | Induce apoptosis of granulosa cells | Reproductive endocrine-mediated perturbations | |
IVR | 1600 mg/kg/day | 1600 mg/kg/day | Induce apoptosis of ovarian follicles | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Induce apoptosis of granulosa cells | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Induce apoptosis of ovarian follicles | Reproductive endocrine-mediated perturbations | |
PMID:29458081 | IVR | 200 mg/kg/day | 200 mg/kg/day | Affects uterine morphology | Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Endometrial carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Alterations in endometrial morphology | Reproductive endocrine-mediated perturbations | |
IVR | 20000 mg/kg/day | - | No significant effects observed | - | |
IVR | 200000 mg/kg/day | 200000 mg/kg/day | Endometrial carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 200000 mg/kg/day | 200000 mg/kg/day | Alterations in endometrial morphology | Reproductive endocrine-mediated perturbations | |
IVR | 200000 mg/kg/day | 200000 mg/kg/day | Uterine carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Endometrial carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Alterations in endometrial morphology | Reproductive endocrine-mediated perturbations | |
PMID:29471507 | IVR | 500 mg/kg/day | 500 mg/kg/day | Affects fertility in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Abnormal estrous cycles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Accelerated onset of puberty in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Accelerated onset of puberty in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects litter size | Reproductive endocrine-mediated perturbations | |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects fertility in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Abnormal estrous cycles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects fertility in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects litter size | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Abnormal estrous cycles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Accelerated onset of puberty in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:29472605 | IVTH | 50 mg/L | 50 mg/L | Lead to obesity | Metabolic endocrine-mediated perturbations |
IVTH | 50 mg/L | 50 mg/L | Causes insulin resistance | Metabolic endocrine-mediated perturbations | |
IVTH | 50 mg/L | 50 mg/L | Decreased triglycerides level | Metabolic endocrine-mediated perturbations | |
IVTH | 50 mg/L | 50 mg/L | Elevated insulin levels | Metabolic endocrine-mediated perturbations | |
PMID:29606031 | IVR | 750 mg/kg/day | 750 mg/kg/day | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Undescended testes (or cryptorchidism) | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
PMID:29663635 | IVR | 500 mg/kg/day | 500 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
PMID:29689378 | IVR | 1 mg/kg/day | 1 mg/kg/day | Prostate carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations |
IVR | 0.01 mg/kg/day | - | No significant effects observed | - | |
IVR | 0.1 mg/kg/day | 0.1 mg/kg/day | Prostate carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
PMID:29707687 | IVR | 1.33 mg/L | 1.33 mg/L | Affects litter size | Reproductive endocrine-mediated perturbations |
IVR | 1.33 mg/L | 1.33 mg/L | Decreased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 1.33 mg/L | 1.33 mg/L | Decreased uterine weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1.33 mg/L | 1.33 mg/L | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.133 mg/L | - | No significant effects observed | - | |
PMID:29753845 | IVR | 200 mg/kg | 200 mg/kg | Changes in placental morphology | Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg | 200 mg/kg | Affects placental function | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Reduced insulin levels | Metabolic endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Affects expression of thyroid receptor (TR) | Metabolic endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Changes in placental morphology | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects placental function | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects expression of thyroid receptor (TR) | Metabolic endocrine-mediated perturbations | |
PMID:29774754 | IVR | 30 mg/kg/day | 30 mg/kg/day | Increased LH levels | Reproductive endocrine-mediated perturbations |
IVR | 30 mg/kg/day | 30 mg/kg/day | Alters hypothalamic-pituitary-gonadal axis (HPG axis) | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Increased FSH levels | Reproductive endocrine-mediated perturbations | |
PMID:29777495 | IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
PMID:29805520 | IVTH | 0.000001 M | 0.000001 M | Cancer phenotype | Endocrine-mediated cancer |
IVTH | 0.00000001 M | 0.00000001 M | Cancer phenotype | Endocrine-mediated cancer | |
PMID:29842840 | IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased liver weights | Hepatic endocrine-mediated perturbations |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
PMID:29940330 | IVR | 500 mg/kg/day | 500 mg/kg/day | Affects blood-testis barrier (BTB) | Reproductive endocrine-mediated perturbations |
IVR | 250 mg/kg/day | - | No significant effects observed | - | |
PMID:29945229 | IVR | 300 mg/kg | 300 mg/kg | Affects testicular function | Reproductive endocrine-mediated perturbations |
IVR | 300 mg/kg | 300 mg/kg | Increased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg | 30 mg/kg | Affects testicular function | Reproductive endocrine-mediated perturbations | |
PMID:29969652 | IVR | 25 mg/kg/day | 25 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations |
IVR | 25 mg/kg/day | 25 mg/kg/day | Affects ovarian follicles population | Reproductive endocrine-mediated perturbations | |
IVR | 25 mg/kg/day | 25 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 25 mg/kg/day | 25 mg/kg/day | Increased FSH levels | Reproductive endocrine-mediated perturbations | |
PMID:30087586 | IVR | 300 mg/kg/day | 300 mg/kg/day | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations |
IVR | 300 mg/kg/day | 300 mg/kg/day | Abnormal neuronal distribution in offspring | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects neuronal signaling | Neurological endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Affects neuronal density in offspring | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Affects neuronal signaling | Neurological endocrine-mediated perturbations | |
PMID:30243084 | IVR | 2000 mg/kg/day | 2000 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Testicular atrophy | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Increased LH levels | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Alterations in number of sertoli cells | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Increased FSH levels | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Affects sperm motility | Reproductive endocrine-mediated perturbations | |
IVR | 2000 mg/kg/day | 2000 mg/kg/day | Affects the biochemical composition of liver | Hepatic endocrine-mediated perturbations | |
PMID:30336312 | IVR | 300 mg/kg/day | 300 mg/kg/day | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects steroidogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects steroidogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased estradiol levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decreased estradiol levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | - | No significant effects observed | - | |
PMID:30362281 | IVR | 100 mg/kg/day | 100 mg/kg/day | Elevated glucose levels in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations |
IVR | 10 mg/kg/day | - | No significant effects observed | - | |
IVR | 1 mg/kg/day | - | No significant effects observed | - | |
PMID:30543897 | IVR | 150 mg/kg/day | 150 mg/kg/day | Affects thyroid function | Metabolic endocrine-mediated perturbations |
IVR | 0.5 mg/kg/day | - | No significant effects observed | - | |
PMID:30550969 | IVR | 5 mg/kg | 5 mg/kg | Affects cytokine signaling | Immunological endocrine-mediated perturbations |
IVR | 500 mg/kg | 500 mg/kg | Affects lipid metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Increased cholesterol levels | Metabolic endocrine-mediated perturbations | |
IVR | 500 mg/kg | 500 mg/kg | Affects cytokine signaling | Immunological endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects cytokine signaling | Immunological endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects lipid metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 5 mg/kg | 5 mg/kg | Affects lipid metabolism | Metabolic endocrine-mediated perturbations | |
PMID:30565266 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects insulin signaling in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased testosterone levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased estradiol levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects glycogen metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Increased Alanine aminotransferase (ALT) levels in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects gluconeogenesis in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects glucose metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects glycogen metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects gluconeogenesis in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects insulin signaling in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Elevated insulin levels in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Increased Alanine aminotransferase (ALT) levels in offspring | Developmental endocrine-mediat | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased estradiol levels in offspring | ||
IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased testosterone levels in offspring | ||
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects glucose metabolism in offspring | ||
IVR | 100 mg/kg/day | 100 mg/kg/day | Elevated insulin levels in offspring | ||
PMID:30597186 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects glucose metabolism | Metabolic endocrine-mediated perturbations |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects glucose metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects liver function | Hepatic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Oxidative stress in liver in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects glucose metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects lipid metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg/day | 10 mg/kg/day | Affects the biochemical composition of liver in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects lipid metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects liver function | Hepatic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects glucose metabolism in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects the biochemical composition of liver in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Oxidative stress in liver in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
PMID:30636900 | IVR | 300 mg/kg/day | 300 mg/kg/day | Induce neuronal apoptosis in offspring | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations |
IVR | 750 mg/kg/day | 750 mg/kg/day | Induce neuronal apoptosis in offspring | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | - | No significant effects observed | - | |
PMID:30649530 | IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Alters sex ratio | Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Alters sex ratio | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | - | No significant effects observed | - | |
IVR | 0.02 mg/kg/day | - | No significant effects observed | - | |
PMID:30716676 | IVR | 300 mg/kg/day | 300 mg/kg/day | Affects thyroid function | Metabolic endocrine-mediated perturbations |
IVR | 300 mg/kg/day | 300 mg/kg/day | Changes in morphology of thyroid gland | Metabolic endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Increase in TSH levels | Metabolic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects thyroid function | Metabolic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Changes in morphology of thyroid gland | Metabolic endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Increase in TSH levels | Metabolic endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Affects thyroid function | Metabolic endocrine-mediated perturbations | |
PMID:30755103 | IVR | 500 mg/kg/day | 500 mg/kg/day | Induce apoptosis in testis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Testicular carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Testicular carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Induce apoptosis in testis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Induce apoptosis in testis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Testicular carcinoma | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations | |
PMID:30769184 | IVTH | 0.00001 M | 0.00001 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations |
IVTH | 0.00001 M | 0.00001 M | Increased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.000001 M | - | No significant effects observed | - | |
PMID:30909102 | IVTH | 0.00001 M | 0.00001 M | Affects expression of progesterone receptor (PR) | Reproductive endocrine-mediated perturbations |
IVTH | 0.00001 M | 0.00001 M | Cancer phenotype | Endocrine-mediated cancer | |
IVTH | 0.00000001 M | 0.00000001 M | Affects expression of progesterone receptor (PR) | Reproductive endocrine-mediated perturbations | |
IVTH | 0.000001 M | - | No significant effects observed | - | |
IVTH | 0.0000001 M | - | No significant effects observed | - | |
IVTH | 0.0000000001 M | - | No significant effects observed | - | |
IVTH | 0.000000001 M | - | No significant effects observed | - | |
PMID:30940548 | IVR | 700 mg/kg/day | 700 mg/kg/day | Alterations in vaginal opening of offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 700 mg/kg/day | 700 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 700 mg/kg/day | 700 mg/kg/day | Increased cholesterol levels in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 700 mg/kg/day | 700 mg/kg/day | Alterations in preputial separation in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 700 mg/kg/day | 700 mg/kg/day | Elevated glucose levels in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 70 mg/kg/day | 70 mg/kg/day | Alterations in vaginal opening of offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 7 mg/kg/day | - | No significant effects observed | - | |
PMID:30989653 | IVR | 675 mg/kg/day | 675 mg/kg/day | Affects spermatogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 675 mg/kg/day | 675 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 675 mg/kg/day | 675 mg/kg/day | Changes in morphology of seminiferous tubules in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 675 mg/kg/day | 675 mg/kg/day | Induce apoptosis in testis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 675 mg/kg/day | 675 mg/kg/day | Affects testicular function in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:31022410 | IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations | |
PMID:31149210 | IVR | 250 mg/kg/day | 250 mg/kg/day | Abnormal estrous cycles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 250 mg/kg/day | 250 mg/kg/day | Decreased testis weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Decreased weights of epididymis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased testis weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased weights of epididymis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Abnormal estrous cycles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 2500 mg/kg/day | 2500 mg/kg/day | Abnormal estrous cycles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:31163220 | IVTH | 100 mg/L | 100 mg/L | Cancer phenotype | Endocrine-mediated cancer |
IVTH | 100 mg/L | 100 mg/L | Affects lipid metabolism | Metabolic endocrine-mediated perturbations | |
IVTH | 100 mg/L | 100 mg/L | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVTH | 200 mg/L | 200 mg/L | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVTH | 200 mg/L | 200 mg/L | Affects embryonic development | Developmental endocrine-mediated perturbations | |
IVTH | 200 mg/L | 200 mg/L | Cancer phenotype | Endocrine-mediated cancer | |
IVTH | 200 mg/L | 200 mg/L | Affects lipid metabolism | Metabolic endocrine-mediated perturbations | |
IVTH | 50 mg/L | 50 mg/L | Affects steroidogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVTH | 50 mg/L | 50 mg/L | Cancer phenotype | Endocrine-mediated cancer | |
IVTH | 50 mg/L | 50 mg/L | Lead to obesity | Metabolic endocrine-mediated perturbations | |
IVTH | 50 mg/L | 50 mg/L | Affects embryonic development | Developmental endocrine-mediated perturbations | |
IVTH | 100 mg/L | 100 mg/L | Affects embryonic development | Developmental endocrine-mediated perturbations | |
PMID:31181066 | IVR | 300 mg/kg/day | 300 mg/kg/day | Reduced sperm counts in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects sperm motility in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased testis weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg/day | 300 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:31211961 | IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects expression of estrogen receptor (ER) in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects ovarian function in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects ovarian function in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects steroidogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Oxidative stress in ovaries | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects steroidogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects ovarian function in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg/day | 750 mg/kg/day | Affects expression of estrogen receptor (ER) in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects ovarian function in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects expression of estrogen receptor (ER) in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects expression of androgen receptor (AR) | Reproductive endocrine-mediated perturbations | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects steroidogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:31297340 | IVR | 400 mg/kg | 400 mg/kg | Affects cytokine signaling | Immunological endocrine-mediated perturbations |
IVR | 400 mg/kg | 400 mg/kg | Affects sperm motility | Reproductive endocrine-mediated perturbations | |
IVR | 400 mg/kg | 400 mg/kg | Affects the biochemical composition of testis | Reproductive endocrine-mediated perturbations | |
IVR | 400 mg/kg | 400 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 400 mg/kg | 400 mg/kg | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 400 mg/kg | 400 mg/kg | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 400 mg/kg | 400 mg/kg | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
PMID:31369804 | IVR | 0.05 mg/kg | 0.05 mg/kg | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations |
IVR | 0.05 mg/kg | 0.05 mg/kg | Affects steroidogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg | 0.05 mg/kg | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg | 0.05 mg/kg | Affects spermatogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.005 mg/kg | - | No significant effects observed | - | |
PMID:31660453 | IVR | 0.133 mg/L | 0.133 mg/L | Alterations in endometrial morphology | Reproductive endocrine-mediated perturbations |
IVR | 0.133 mg/L | 0.133 mg/L | Cancer phenotype | Endocrine-mediated cancer | |
IVR | 1.33 mg/L | 1.33 mg/L | Cancer phenotype | Endocrine-mediated cancer | |
PMID:31771930 | IVR | 200 mg/kg | 200 mg/kg | Affects expression of progesterone receptor (PR) | Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg | 200 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Affects expression of estrogen receptor-alpha (ER-alpha) | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects expression of estrogen receptor-alpha (ER-alpha) | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects expression of progesterone receptor (PR) | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/kg | 50 mg/kg | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00002 M | 0.00002 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.0002 M | 0.0002 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.0002 M | 0.0002 M | Increased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.0005 M | - | No significant effects observed | - | |
PMID:31904422 | IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects litter size | Reproductive endocrine-mediated perturbations |
IVR | 0.2 mg/kg/day | 0.2 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Abnormal estrous cycles | Reproductive endocrine-mediated perturbations | |
IVR | 0.02 mg/kg/day | 0.02 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | - | No significant effects observed | - | |
IVR | 20 mg/kg/day | 20 mg/kg/day | Affects folliculogenesis | Reproductive endocrine-mediated perturbations | |
PMID:31910153 | IVTH | 0.000128 M | 0.000128 M | Affects glucose metabolism | Metabolic endocrine-mediated perturbations |
PMID:31923814 | IVR | 500 mg/kg/day | 500 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations |
IVR | 500 mg/kg/day | 500 mg/kg/day | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 500 mg/kg/day | 500 mg/kg/day | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 250 mg/kg/day | 250 mg/kg/day | Oxidative stress in testis | Reproductive endocrine-mediated perturbations | |
PMID:9146736 | IVR | 5000 mg/L | 5000 mg/L | Changes in liver morphology | Hepatic endocrine-mediated perturbations |
IVR | 5000 mg/L | 5000 mg/L | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 5000 mg/L | 5000 mg/L | Changes in morphology of thyroid gland | Metabolic endocrine-mediated perturbations | |
IVR | 5000 mg/L | 5000 mg/L | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 50 mg/L | - | No significant effects observed | - | |
IVR | 500 mg/L | 500 mg/L | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 5 mg/L | - | No significant effects observed | - | |
IVR | 500 mg/L | 500 mg/L | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.